PHR Phreesia, Inc. Insider Trading

10% owner Pale Fire Capital SE purchases 1,275,500 shares (1.28M) at $8.20 avg over 3 days; stock down -74.3% from 52-week high, -32.3% in 30d

Pale Fire Capital SE, a 10% owner of Phreesia, executed 3 separate purchases totaling 1,275,500 shares for $10,464,823.00 across March 31–April 2, 2026, at a blended average price of $8.20. The accumulation increased holdings by 16.7% from 7,648,829 to 8,924,329 shares. This activity occurs against a backdrop of severe price deterioration: the current price of $8.37 represents -74.3% from the 52-week high of $32.55 and a -32.3% decline over the prior 30 days. Phreesia's fundamentals remain intact (Revenue $120,333,000.00 with +14.5% annual growth, P/E 9.20), suggesting the buying may reflect valuation dislocation rather than deterioration in business quality. However, Pale Fire's prior buys at this ticker (3 trades on March 17, 18, and 19) lack measurable outcomes; the cross-ticker track record shows only 3 prior buys with no timing pattern disclosed, limiting confidence in the signal's predictive power. The magnitude of capital deployed ($10.5M) and the timing within days of earlier purchases warrant close attention to whether this represents accumulation during a deep drawdown or exposure to unfolding operational headwinds not yet visible in the latest reported financials.

Pale Fire Capital SE purchases 1,602,505 shares (1.60M) for $18,304,679.58 across 3 days at $11.15–$11.69, raising stake to 7.65M shares (+26.5%)

Pale Fire Capital SE, a 10% owner, made 3 separate purchases totaling 1,602,505 shares for $18,304,679.58 at a blended average price of $11.42 between March 17–19, 2026. This represents a 26.5% increase in the investor's position, from 6,046,324 shares to 7,648,829 shares. The purchases occurred while the stock was trading near its 52-week low ($10.97), down -63.8% from its 52-week high of $32.55, and the company recently reported a negative full-year net income despite 17.8% annual revenue growth. The substantial capital deployment and aggressive accumulation during a period of significant stock depreciation merit investor attention to understand the investor's rationale and confidence level in the recovery thesis.

Roberts (President, Provider Solutions, PHR) sold 48,547 shares for $1,555,971.87; holds 724,368 post-sale (-6.3%)

Roberts executed 2 separate sales totaling 48,547 shares for $1,555,971.87, reducing his holdings by 6.3% from 772,915 to 724,368 shares. The transactions occurred near the 52-week high ($32.55), with sales priced at $32.02 and $32.46 (blended average $32.05), only 1.2% below the peak. Notably, Roberts' same-ticker history at PHR shows 5 of 5 prior sells were well-timed at the 90-day mark—each followed by stock declines—and his cross-ticker track record across all holdings shows a 100.00% well-timed rate on 7 prior sales. This latest sale arrives amid positive short-term momentum (+17.1% over 30 days, +29.3% over 90 days) but as the company remains unprofitable with a full-year net income of $-3,914,000.00 despite revenue growth of +17.8%, establishing a material context for insider liquidation despite near-peak pricing.

CEO Indig Chaim sold 99,993 shares of PHR over 2 days for $3.2M at $32.05 blended average; prior 5 PHR trades all well-timed at 90-day horizon.

Indig Chaim, CEO of Phreesia, sold 2 separate tranches totaling 99,993 shares for $3,204,911.51 at a blended average price of $32.05 on August 27–28, 2025, reducing his holdings from 1,353,229 to 1,253,236 shares. His prior 5 trades at PHR were all well-timed at the 90-day mark, a 100% success rate that stands out against his cross-ticker track record (90d well-timed rate 100.00%). The stock is currently trading at $31.66, down 2.7% from the 52-week high of $32.55 (very close to the transaction price), and has posted strong recent momentum: +17.1% over 30 days and +29.3% over 90 days. The company remains unprofitable (net income $-3.9M in the latest quarter) despite solid revenue growth of +17.8% year-over-year, suggesting continued execution risk. Given the CEO's historically precise sell timing at this ticker and the unprofitable revenue trajectory, this transaction warrants close monitoring of quarterly results and forward guidance.

Phreesia President David Linetsky sold 17,445 shares at $29.73 (518.7K), reducing stake by 9.1%

David Linetsky, President of Network Solutions at Phreesia, Inc., sold 17,445 shares for $518,681.72 at $29.73 per share on 2025-08-22, reducing his holdings from 191,447 shares to 174,002 shares. The company faces profitability headwinds: while revenue growth is strong at +17.8% year-over-year and the latest quarter posted $115.9M in revenue, the company reported $-3.9M in net income last quarter and was unprofitable over its most recent full fiscal year. The stock has appreciated significantly in recent periods (30-day change: +15.7%, 90-day change: +32.2%) and is trading at a $30.80 current price near its 52-week high of $30.80. The sale represents a material reduction in executive holdings, though Linetsky retains 174.0K shares post-transaction.

PHR COO Roberts sells 19,591 shares for $588.2K near 52-week high; prior sales at this ticker 100% well-timed over 90 days.

Evan Roberts, Chief Operating Officer of Phreesia, Inc., executed 2 separate sales totaling 19,591 shares for $588,190.61 at prices of $30.00 and $30.13 on consecutive days (2025-02-13 and 2025-02-14), reducing his holdings from 764,307 shares to 744,716 shares (a -2.6% reduction). The sales occurred at $30.02 blended average price, matching the current price and only 0.0% below the 52-week high of $30.01, at a point when the stock has gained 10.2% over the prior 30 days and 62.0% over the prior 90 days. Roberts' prior 4 measurable sales at PHR all resulted in negative 90-day returns (ranging from -4.6% to -20.3%), meaning the insider sold before subsequent declines in all cases—a 100% well-timed rate at this ticker. Against this backdrop, the company remains unprofitable (net income $-14.4M in the latest quarter, negative full-year result), though revenue grew 26.8% year-over-year and the current market cap stands at $1.7B. The timing pattern—selling at or near a multi-month peak following a steep run-up—aligns with Roberts' historical PHR trading accuracy.

CFO Gandhi Balaji sells 33,648 shares (23.2% of holdings) at $30.00–$30.09 for $1.0M at 52-week highs

Gandhi Balaji sold 33,648 shares across two separate transactions on 2025-02-13 and 2025-02-14 at prices of $30.00 and $30.09, reducing his holdings from 144,933 to 111,285 shares. The sales occurred at the company's 52-week high of $30.01, coinciding with a 62.0% gain over the prior 90 days and a 10.2% gain over the prior 30 days. Against this backdrop, Phreesia remains unprofitable (full-year net income was negative at $-14,403,000.00) despite 26.8% annual revenue growth. The sale of over one-fifth of the CFO's holdings at peak valuation levels, while the company operates at a loss, merits investor attention to understand the strategic context and any forward guidance implications.

CEO Indig Chaim sold 26,248 shares (26.2K) for $721,197.87 in 2 separate transactions at PHR, near 52-week high.

Indig Chaim, CEO of Phreesia, executed 2 separate sales totaling 26,248 shares for $721,197.87 on 2025-01-27, reducing his holdings by 2.0% to 1,260,200 shares. The sales occurred at a blended average price of $27.48, within 2.0% of the 52-week high of $29.29, at a time when the stock has gained 11.6% over 30 days and 57.0% over 90 days. Across his cross-ticker track record, the CEO's prior 3 open-market sells achieved a 100.00% well-timed rate at the 90-day mark, with an average 90-day return of -6.0% after those sales. At Phreesia specifically, 2 of 2 prior measurable sells (conducted 2024-01-16 and 2024-01-17) were well-timed at the 90-day mark, posting -7.3% and -4.6% returns respectively after the sale. The company posted $106,800,000 in quarterly revenue with annual growth of +26.8%, but remains unprofitable, reporting a net loss of $-14,403,000 in the most recent full fiscal year. The timing of this sale near the 52-week high, combined with the CEO's prior pattern of well-timed exits and the company's continued losses despite revenue growth, warrants investor attention to execution and profitability trajectory.

CEO Indig Chaim sells 21,692 shares of Phreesia at $27.31; holds 1.24M shares post-transaction in unprofitable, high-growth company.

Indig Chaim sold 21,692 shares (-1.7% of pre-transaction holdings) at $27.31 on 2025-01-21, retaining a substantial 1,237,538 shares. The timing is notable: his prior 2 trades at Phreesia (both sells in January 2024) posted negative 90-day returns of -4.6% and -7.3%, reflecting a 100% well-timed sell rate at this ticker. His cross-ticker track record shows 2 prior sells with a 100.00% well-timed rate (90d return avg of -6.0%), suggesting consistent pattern recognition around near-term price inflection. Phreesia trades at $27.22 currently, off -5.7% from its 52-week high of $28.86 and up +50.0% over 90 days—a material rally that may have triggered this disciplined reduction. The company remains unprofitable (net income $-14.4M on revenue $106.8M) despite +26.8% annual growth, creating fundamental tension between expansion narrative and cash burn that a lengthy holder would monitor carefully.

COO Evan Roberts sells 25,000 PHR shares at $24.09; prior 4 sells at PHR 100% well-timed (all followed by declines)

Evan Roberts, Chief Operating Officer of Phreesia, sold 25,000 shares (25.0K shares) at $24.09 on 2024-12-10, reducing his position from 753.9K to 728.9K shares. His track record at this ticker is notably strong: all 4 prior open-market sells at PHR were well-timed at the 90-day mark, with cumulative 90-day returns of -17.0%, -20.3%, -4.6%, and -7.3%, indicating consistent patterns of selling before subsequent declines. While the company maintains solid revenue growth of +26.8% annually and a $1.4B market cap, it remains unprofitable with net income of $-14.4M in the latest quarter. The current price of $24.55 is -14.9% from the 52-week high, though the stock has moved +14.9% over the prior 30 days, creating tactical ambiguity about near-term momentum versus longer-term fundamentals.